CMR INTERNATIONAL
A Wholly Owned Subsidiary Of China Merchants Bank
Poly Develop - A (600048 CH)
BUY (Maintain)
Healthy balance sheet drives future growth
Target Price
RMB22.16
(Previous TP
RMB22.16)
Up/downside
+44.3%
Revenue and net profit slightly increased by 5.1% to RMB117.4bn and 2.9% to
Current Price
RMB15.36
RMB13.2bn in 9M20, respectively. We believe its ample land bank and healthy
balance sheet provide war chest for its future development. Our TP is RMB22.16,
China Property Sector
which is equivalent to 8.0x 2020E P/E. Reiterate BUY recommendation.
Samson Man, CFA
Net profit gained 3%% in 9M20. Revenue and net profit slightly increased
by 5.1% to RMB117.4bn and 2.9% to RMB13.2bn in 9M20, respectively.
Gross margin slightly retreated by 1.9ppts to 34.0% in the period but stood
at the high level among peers. The Company managed cost well. Selling
Bowen Li
expenses declined by 3.6% to RMB3.3bn and administrative expenses only
gained by 2.0% to RMB3.2bn in the period. So net profit margin only lost
0.2ppts to 11.2% in 9M20.
Outperformed contracted sales. Contracted sales amount and area
Stock Data
Mkt Cap (RMB mn)
increased by 5.9% to RMB367.4bn and 6.6% to 24.44mn sq m in 9M20,
183,811
Avg 3 mths t/o (RMB mn)
1,364
respectively. It is better than the national property sales performance of 3.7%
52w High/Low (RMB)
18.70/13.40
(in amount) and -1.8% (in area), respectively. We believe the leading brand
Total Issued Shares (mn)
11,967
name would support its sales job. And we expect it to achieve another record
high contracted sales in 2020, compared with RMB461.8bn in 2019.
Shareholding Structure
Healthy balance sheet secures long term growth. Poly Development is a
40.7%
China Poly Group
SOE and enjoys a lower funding cost. In addition, it has a healthy balance
Free float
59.3%
sheet. Net gearing ratio and cash/ST debt were 71% and 1.9x as of 30 Sep
2020, respectively. Furthermore, total liabilities/total assets (after deduction of
Share Performance
contract liabilities) was 0.67x as of 30 Sep 2020. So Poly Development passes
the recent new capital test. The Company gains advantage for its long-term
growth because it can be better utilitizing debt financing.
211m sq m attributable land bank. The Company acquired 88 projects with
Source: Bloomberg
total GFA of 19.82mn sq m with total considerations of RMB131.4bn in 9M20.
12-mth Price Performance
Sep 2020, GFA under development and for future development were
140.2mn sq m and 70.8mn sq m. So total attributable land bank of 211mn
sq m is sufficient for next five years development.
Maintain TP and forecast unchanged. We maintain our earnings forecast
unchanged. We forecast net profit to be RMB33.0bn in 2020 and
RMB38.4bn in 2021. Our target price is RMB22.16, based on 8.0x 2020E
P/E. Maintain BUY recommendation.
Earnings Summary
Source: Bloomberg
Auditor: BDO
Related Reports
One of the fastest growing
Interim profit surged 59%" â€“ 22 Jul
Source: Bloomberg, CMBIS estimates
Disclosures & Disclaimers
Analyst Certification
The research analyst who is primary responsible for the content of this research report, in whole or in part, certifies that with respect to the securities
or issuer that the analyst covered in this report: (1) all of the views expressed accurately reflect his or her personal views about the subject securities
or issuer; and (2) no part of his or her compensation was, is, or will be, directly or indirectly, related to the specific views expressed by that analyst
in this report.
Besides, the analyst confirms that neither the analyst nor his/her associates (as defined in the code of conduct issued by The Hong Kong Securities
and Futures Commission) (1) have dealt in or traded in the stock(s) covered in this research report within 30 calendar days prior to the date of issue
of this report; (2) will deal in or trade in the stock(s) covered in this research report 3 business days after the date of issue of this report; (3) serve
as an officer of any of the Hong Kong listed companies covered in this report; and (4) have any financial interests in the Hong Kong listed companies
covered in this report.
CMBIS Ratings
BUY
: Stock with potential return of over 15% over next 12 months
HOLD
: Stock with potential return of +15% to -10% over next 12 months
SELL
: Stock with potential loss of over 10% over next 12 months
OUTPERFORM
: Industry expected to outperform the relevant broad market benchmark over next 12 months
MARKET-PERFORM
: Industry expected to perform in-line with the relevant broad market benchmark over next 12 months
UNDERPERFORM
: Industry expected to underperform the relevant broad market benchmark over next 12 months
CMB International Securities Limited
CMB International Securities Limited ("CMBIS") is a wholly owned subsidiary of CMB International Capital Corporation Limited (a wholly owned subsidiary
of China Merchants Bank)
Important Disclosures
There are risks involved in transacting in any securities. The information contained in this report may not be suitable for the purposes of all investors. CMBIS
does not provide individually tailored investment advice. This report has been prepared without regard to the individual investment objectives, financial position
or special requirements. Past performance has no indication of future performance, and actual events may differ materially from that which is contained in
the report. The value of, and returns from, any investments are uncertain and are not guaranteed and may fluctuate as a result of their dependence on the
performance of underlying assets or other variable market factors. CMBIS recommends that investors should independently evaluate particular investments
and strategies, and encourages investors to consult with a professional financial advisor in order to make their own investment decisions.
This report or any information contained herein, have been prepared by the CMBIS, solely for the purpose of supplying information to the clients of CMBIS or
its affiliate(s) to whom it is distributed. This report is not and should not be construed as an offer or solicitation to buy or sell any security or any interest in
securities or enter into any transaction. Neither CMBIS nor any of its affiliates, shareholders, agents, consultants, directors, officers or employees shall be
liable for any loss, damage or expense whatsoever, whether direct or consequential, incurred in relying on the information contained in this report. Anyone
making use of the information contained in this report does so entirely at their own risk.
The information and contents contained in this report are based on the analyses and interpretations of information believed to be publicly available and reliable.
CMBIS has exerted every effort in its capacity to ensure, but not to guarantee, their accuracy, completeness, timeliness or correctness. CMBIS provides the
information, advices and forecasts on an "AS IS" basis. The information and contents are subject to change without notice. CMBIS may issue other
publications having information and/ or conclusions different from this report. These publications reflect different assumption, point-of-view and analytical
methods when compiling. CMBIS may make investment decisions or take proprietary positions that are inconsistent with the recommendations or views in
this report.
CMBIS may have a position, make markets or act as principal or engage in transactions in securities of companies referred to in this report for itself and/or
on behalf of its clients from time to time. Investors should assume that CMBIS does or seeks to have investment banking or other business relationships with
the companies in this report. As a result, recipients should be aware that CMBIS may have a conflict of interest that could affect the objectivity of this report
and CMBIS will not assume any responsibility in respect thereof. This report is for the use of intended recipients only and this publication, may not be
reproduced, reprinted, sold, redistributed or published in whole or in part for any purpose without prior written consent of CMBIS.
Additional information on recommended securities is available upon request.
For recipients of this document in the United Kingdom
(as amended from time to time) ("The Order") or (II) are persons falling within Article 49(2) (a) to (d) ("High Net Worth Companies, Unincorporated Associations,
etc.,) of the Order, and may not be provided to any other person without the prior written consent of CMBIS.
For recipients of this document in the United States
CMBIS is not a registered broker-dealer in the United States. As a result, CMBIS is not subject to U.S. rules regarding the preparation of research reports
and the independence of research analysts. The research analyst who is primary responsible for the content of this research report is not registered or
qualified as a research analyst with the Financial Industry Regulatory Authority ("FINRA"). The analyst is not subject to applicable restrictions under FINRA
Rules intended to ensure that the analyst is not affected by potential conflicts of interest that could bear upon the reliability of the research report. This report
is intended for distribution in the United States solely to "major US institutional investors", as defined in Rule 15a-6under the US, Securities Exchange Act of
1934, as amended, and may not be furnished to any other person in the United States. Each major US institutional investor that receives a copy of this report
by its acceptance hereof represents and agrees that it shall not distribute or provide this report to any other person. Any U.S. recipient of this report wishing
to effect any transaction to buy or sell securities based on the information provided in this report should do so only through a U.S.-registered broker-dealer.
For recipients of this document in Singapore
This report is distributed in Singapore by CMBI (Singapore) Pte. Limited (CMBISG) (Company Regn. No. 201731928D), an Exempt Financial Adviser as
defined in the Financial Advisers Act (Cap. 110) of Singapore and regulated by the Monetary Authority of Singapore. CMBISG may distribute reports produced
by its respective foreign entities, affiliates or other foreign research houses pursuant to an arrangement under Regulation 32C of the Financial Advisers
Regulations. Where the report is distributed in Singapore to a person who is not an Accredited Investor, Expert Investor or an Institutional Investor, as defined
in the Securities and Futures Act (Cap. 289) of Singapore, CMBISG accepts legal responsibility for the contents of the report to such persons only to the
extent required by law. Singapore recipients should contact CMBISG at +65 6350 4400 for matters arising from, or in connection with the report.